Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients / 감염과화학요법
Infection and Chemotherapy
;
: 792-795, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-914615
ABSTRACT
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes.This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de prevalencia
Idioma:
Inglés
Revista:
Infection and Chemotherapy
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS